Use of neuro-psychiatry medicines in patients with sexual dysfunction: a retrospective study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20170813Keywords:
Andrology, Neuropsychiatry medicines, Retrospective study, Sexual dysfunctionAbstract
Background: The objective of the study was to understand the usage of neuro-psychiatry medicines in patients presenting with symptoms of sexual dysfunction.
Methods: Medical records of adult patients consulting in the clinic out patients with symptoms of sexual dysfunction were screened for prescriptions of neuropsychiatry medicines. Common neuropsychiatric co-morbidities and prevalence of usage of medicines used for treating neuro-psychiatric disorders was calculated.
Results: A total of 628 patients with sexual disorders were included of which 57 (9.1%) had received at least one neuro-psychiatry medicine at the time of presentation. Three most common sexual problems were unconsummated marriage 16 (28.1%), psychogenic ED 14 (24.6%) and organic erectile dysfunction 8 (14.0%). A total of erectile dysfunction 46 (7.3%) patients had psychiatric comorbidity. Five most common neuropsychiatric co-morbidities were anxiety 14 (30.4%), schizhophrenia 10 (21.7%), stress 7 (15.2%), depression 6 (13.0%) and epilepsy 2 (4.3%). The most commonly used neuro-psychiatry medicines were fluoxetine 15 (19.7%), risperidone 11 (14.5%), clonazepam 10 (13.2%), escitalopram 9 (11.8%), alprazolam 5 (6.6%), olanzapine 5 (6.6%) and gabapentin 4 (5.3%). Amisulpride was used in 3 (3.9%) patients whereas valproate, fluoxamine, diazepam and paroxetine were used in 2 (2.6%) patients each. Phenytoin, imipramine, carbamazepine, venlafaxine, haloperidol and sertarline were used in one patient each.
Conclusions: Anxiety, schizophrenia and depression are the most common neuropsychiatric disorders in patients with sexual dysfunction. Many patients presenting with sexual dysfunction are already on neuropsychiatry medicines. Further studies are required to evaluate the association between neuropsychiatry medicines and sexual dysfunction in Indian patients.
Metrics
References
Mourikis I, Antoniou M, Matsouka E, Vousoura E, Tzavara C, Ekizoglou C, et al. Anxiety and depression among Greek men with primary erectile dysfunction and premature ejaculation. Ann Gen Psychiatry. 2015;14:34.
Urso L, Zummo L, Gammino M, Fierro B, Pavone C, Daniele O. Antiepileptic Drugs, Sexual Functions and Serum Hormonal Profile in Males with Epilepsy. Med Surg Urol. 2014;3:1.
Ahmadzadeh G, Shahin A. Sexual dysfunctions in the patients hospitalized in psychiatric wards compared to other specialized wards in Isfahan, Iran, in 2012. Adv Biomed Res. 2015;4:225.
Hamed SA, Ahmad HK, Youssef AH, Metwaly NAH, Hassan MM, Mohamad HO. Erectile function in men with epilepsy: relationship to psychosocial, hormonal-, epilepsy- and antiepileptic drugs-related variables Journal of Neurology and Neuroscience. 2013;4(2):5.
Henning OJ, Nakken KO, Traeen B, Mowinckel P, Lossius M. Sexual problems in people with refractory epilepsy. Epilepsy Behave. 2016;61:174-9.
Outhoff K. Antidepressant-induced sexual dysfunction. SA Fam Pract. 2009;51:298-302.
Hou CL, Zang Y, Rosen RC, Cai MY, Li Y, Jia FJ, et al. Sexual dysfunction and its impact on quality of life in Chinese patients with schizophrenia treated in primary care. Comp Psychiatry. 2016;65:116-21.
Osis L, Bishop JR. Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals. 2010;3:3614-28.
La Torre A, Conca A, Duff y D, Giupponi G, Pompili M, Grözinger M. Sexual dysfunction related to psychotropic drugs: A critical review Part II: Antipsychotics. Pharmacopsychiatry. 2013;46:201-8.
Nagaraj AKM, Pai NB, Rao S. A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine. Indian J Psychiatry. 2009;51:265-71.
Jhanjee A, Kumar P, Gupta NK. Antidepressant-induced sexual dysfunction: A comparison between duloxetine and escitalopram. Delhi Psychiatry Journal. 2010;13:89-93.
Rizvi SJ, Kennedy SH. Psychopharmacology for the Clinician. J Psychiatry Neurosci. 2013:E27-28.
Bozkurt M, Gocmez C, Soylemez H, Daggulli M, Em S, Yildiz M, et al. Association between neuropathic pain, pregabalin treatment, and erectile dysfunction. J Sex Med. 2014;11:1816-22.
Bodie JA, Beeman WW, Monga M. Psychogenic erectile dysfunction. Int J Psychiary Med. 2003;33:273-93.
Hocaoglu C, Celik FH, Kandemir G, Guveli H, Bahceci B. Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study. Shanghai Arch Psychiatry. 2014;26:347-56.
Tharror H, Kaliappan A, Gopal S. Sexual dysfunctions in schizophrenia: Professionals and patients perspectives. Indian J Psychiatry. 2015;57:85-7.
de Boer MK, Castelein S, Wiersma D, Schoevers RA, Knegtering H. The facts about sexual (Dys) function in schizophrenia: an overview of clinically relevant findings. Schizophr Bull. 2015;41:674-86.
Xia Y, Li J, Shan G, Qian H, Wang T, Wu W, et al. Relationship between premature ejaculation and depression: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95:e4620.
Waldinger MD. Psychiatric disorders and sexual dysfunction. Handb Clin Neurol. 2015;130:469-89.
Jacobsen PL, Mahableshwarkar AR, Chen Y, Chrones L, Clayton AH. Effect of vortioxetine vs. escitalopram on sexual functioning in adults with well-treated major depressive disorder experiencing SSRI-induced sexual dysfunction. J Sex Med. 2015;12:2036-48.
Fossey MD, Hamner MB. Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety. 1995;1:233-6.
Keller J, Chen YK, Lin HC. Association between epilepsy and erectile dysfunction: evidence from a population-based study. J Sex Med. 2012;9:2248-55.
Bone B, Janszky J. Epilepsy and male sexual dysfunction: etiology, diagnosis and therapy. Ideggyogy Sz. 2006;29:148-52.
Najafi MR, Ansari B, Zare M, Fatehi F, Sonbolestan A. Effects of antiepileptic drugs on sexual function and reproductive hormones of male epileptic patients. Ir J neurol. 2012;11:37-41.
Yang Y, Wang X. Sexual dysfunction related to antiepileptic drugs in patients with epilepsy. Expert Opion Drug Saf. 2016;15:31-42.
Taegtmeyer AB, Krahenbuhl S. Drug-induced sexual dysfunction. Ther Umsch. 2015;72:711-5.